Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft.
Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Krestyaninov O, Khelimskii D, Jaffer FA, Khatri JJ, Kandzari DE, Wyman RM, Doing AH, Dattilo P, Toma C, Yeh RW, Tamez H, Choi JW, Jaber W, Samady H, Sheikh AM, Potluri S, Patel M, Mahmud E, Elbaruni B, Love MP, Koutouzis M, Tsiafoutis I, Jefferson BK, Patel T, Uretsky B, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Hall AB, Megaly MS, Vemmou E, Nikolakopoulos I, Rangan BV, Morley PW, Bou Dargham B, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES, Alaswad K. Xenogiannis I, et al. Among authors: kandzari de. JACC Cardiovasc Interv. 2020 Feb 24;13(4):517-526. doi: 10.1016/j.jcin.2019.10.028. JACC Cardiovasc Interv. 2020. PMID: 32081243 Free article.
Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results.
Stone GW, Colombo A, Teirstein PS, Moses JW, Leon MB, Reifart NJ, Mintz GS, Hoye A, Cox DA, Baim DS, Strauss BH, Selmon M, Moussa I, Suzuki T, Tamai H, Katoh O, Mitsudo K, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Serruys PW. Stone GW, et al. Among authors: kandzari de. Catheter Cardiovasc Interv. 2005 Oct;66(2):217-36. doi: 10.1002/ccd.20489. Catheter Cardiovasc Interv. 2005. PMID: 16155889 Review. No abstract available.
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ, Simonton CA, Garg J, Lokhnygina Y, Mancini GB, Yeoh E, Buller CE; ACROSS/TOSCA-4 Investigators. Kandzari DE, et al. JACC Cardiovasc Interv. 2009 Feb;2(2):97-106. doi: 10.1016/j.jcin.2008.10.013. JACC Cardiovasc Interv. 2009. PMID: 19463409 Free article.
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Waseda K, et al. Among authors: kandzari de. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015. JACC Cardiovasc Interv. 2009. PMID: 19695548 Free article. Clinical Trial.
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB. Kirtane AJ, et al. Among authors: kandzari de. JACC Cardiovasc Interv. 2009 Oct;2(10):967-76. doi: 10.1016/j.jcin.2009.08.008. JACC Cardiovasc Interv. 2009. PMID: 19850257 Free article. Clinical Trial.
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS Jr, Popma JJ; ENDEAVOR IV Investigators. Leon MB, et al. Among authors: kandzari de. JACC Cardiovasc Interv. 2009 Dec;2(12):1208-18. doi: 10.1016/j.jcin.2009.10.008. JACC Cardiovasc Interv. 2009. PMID: 20129547 Free article. Clinical Trial.
Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention.
Lee MS, Bokhoor P, Park SJ, Kim YH, Stone GW, Sheiban I, Biondi-Zoccai G, Sillano D, Tobis J, Kandzari DE. Lee MS, et al. Among authors: kandzari de. JACC Cardiovasc Interv. 2010 Aug;3(8):791-5. doi: 10.1016/j.jcin.2010.06.005. JACC Cardiovasc Interv. 2010. PMID: 20723848 Free article. Review.
366 results